Home>Topics>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals PGNX

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. FDA clears OIC drug

      Headlines

      Tue, 16 Sep 2014

      induced constipation who take opioids for the management of chronic non-cancer pain. Movantik is distributed by AstraZeneca ( AZN -0.9% ). Related tickers: ( PGNX -0.2% ) ( SLXP +3.7% ) ( CBST +0.1% ) Post your comment!

    2. Progenics Pharma settles arbitration with Ono Pharma

      Headlines

      Fri, 5 Sep 2014

      Progenics Pharmaceuticals ( PGNX -2.4% ) settles its arbitration with Ono Pharmaceutical Company over Ono's rights to subcutaneous Relistor in Japan and its

    3. 2nd Half Of 2014 Biotechnology Catalysts - Part 4

      Headlines

      Sun, 17 Aug 2014

      By Alexander Maxwell : Having previously updated the investment community in part 3 of my Biotechnology Catalysts series, the purpose of this article is to help give investors an idea of the upcoming biotechnology catalysts through the end of September. It can be hard for investors to be able to ...

    4. Investor or Speculator?

      Headlines

      Tue, 12 Aug 2014

      Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted

    5. PDUFA date set for Relistor

      Headlines

      Mon, 11 Aug 2014

      bromide) for treatment of opioid-induced constipation. Salix successfully appealed a CRL that the agency issued on July 27, 2012. Related tickers: (NASDAQ: PGNX ) (NASDAQ: NKTR ) (NYSE: AZN ) (NASDAQ: CBST ) Post your comment!

    6. Progenics Pharmaceuticals' ( PGNX ) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Fri, 8 Aug 2014

      Progenics Pharmaceuticals (NASDAQ: PGNX ) Q2 2014 Earnings Call August 08, 2014 8:30 am ET ..... Good day, ladies and gentlemen, and welcome to the Progenics Pharmaceuticals Second Quarter 2014 Results Conference Call. [Operator

    7. More on Progenics Pharma Q2 results

      Headlines

      Fri, 8 Aug 2014

      Progenics Pharmaceuticals (NASDAQ: PGNX ) Q2 results : Revenues: $1.5M (-16.7%); Operating Expenses: $12.6M (-10.6%); Operating Loss: ($11.1M

    8. Progenics Pharmaceuticals ( PGNX ) Q2 2014 Results - Earnings Call Webcast

      Headlines

      Fri, 8 Aug 2014

      The following audio is from a conference call that will begin on August 08, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now If you would like to view a transcript of this call, please click here. Complete Story »

    9. Progenics Pharmaceuticals misses by $0.03, misses on revenue

      Headlines

      Fri, 8 Aug 2014

      Progenics Pharmaceuticals (NASDAQ: PGNX ): Q2 EPS of -$0.17 misses by $0.03 . Revenue of $1.5M (-16.7% Y/Y) misses by $1.33M . Press Release Post your comment!

    10. Notable earnings before Friday’s open

      Headlines

      Thu, 7 Aug 2014

      BAM , BECN , BID , BPL , CCC , CHH , EBIX , ERF , HMSY , HRG , LXU , MGA , MHR , PDCE , PGEM , PGNX , RDNT , SIRO , SUSP , SUSS , TTI Post your comment!

    « Prev12345Next »
    Content Partners